Hepatitis B Treatment Companies
Companies involved in Hepatitis B treatment generally engage in research, development, manufacturing, and commercialization of antiviral medications designed to treat Hepatitis B.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Latest Hepatitis B Treatment Companies Update:
Brii Bio Their novel drug BRII-179 (VBI-2601) demonstrated encouraging results in Phase 2 trials for achieving a functional cure for Hepatitis B (HBV), meaning undetectable HBV surface antigen and viral DNA after stopping therapy. Phase 3 trials are ongoing.
Gilead Sciences Conducting a Phase 2 trial exploring a combination of their drugs Tenofovir Alafenamide (TAF) and VIR-2218 with other novel therapies for potential functional cure. Results expected in early 2024.
Madrigal Therapeutics Their drug Resmetirom received a New Drug Application (NDA) acceptance from the US FDA for treatment of chronic hepatitis B, with a decision expected by mid-March 2024. This could be a major milestone for the market.
Janssen's exit Unfortunately, the pharmaceutical giant announced its departure from the Hepatitis B treatment market in February 2023, raising concerns about access and innovation.
List of Hepatitis B Treatment Key companies in the market
- Accord Healthcare Inc.
- Apotex Corp.
- Arbutus Biopharma
- Arrowhead Pharma
- Aurobindo Pharma Limited
- Bristol-Myers Squibb Company
- Gilead Sciences, Inc.
- GlaxoSmithKline
- Lupin Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Par Pharmaceutical, Inc.
- Teva Pharmaceuticals
- Zydus Pharmaceuticals
Hepatitis B Treatment Market Highlights:
Hepatitis B Treatment Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
